Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Comprehensive genomic profiling of advanced anal adenocarcinoma.
Authors
Nozomu Ogura
Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
Nozomu Ogura , Hidekazu Hirano , Kouya Shiraishi , Hiroyuki Fujii , Toshiharu Hirose , Hirokazu Shoji , Natsuko Tsuda Okita , Atsuo Takashima , Takafumi Koyama , Ken Kato
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 4)
DOI
10.1200/JCO.2024.42.3_suppl.4
Abstract #
4
Poster Bd #
B14
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss).
First Author: Natalie Ngoi
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic landscape in small intestine cancer from real-world data (RWD) of clinical genomic testing.
First Author: Hiroyuki Takeda
Poster
2018 ASCO Annual Meeting
Comprehensive genomic characterization of chemotherapy-resistant testicular germ cell tumors (TGCT).
First Author: Andrea Necchi
Poster
2018 Genitourinary Cancers Symposium
Refractory testicular pure seminoma (PS) and non-seminomatous(NS) germ cell tumors (GCT): A comprehensive genomic profiling (CGP) study.
First Author: Joseph M Jacob